Voyageur Pharmaceuticals Advances Frances Creek Project, Paving the Way for a Secure, Vertically Integrated Barium Contrast Product Line
Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the commencement of the Frances Creek barium contrast media project, powered by a ...
Pharmabiz7d
Bayer presents positive results from phase III study QUANTI CNS of gadoquatrane at ECR 2025
Bayer presents positive results from phase III study QUANTI CNS of gadoquatrane at ECR 2025: Berlin Thursday, February 27, 2025, 14:00 Hrs [IST] Bayer, a global leader in radiolog ...
Late-breaking data from QUANTI CNS (Central Nervous System) presented at ECR 2025:
Bayer, a global leader in radiology, announced positive results from the Phase III study QUANTI CNS, which evaluated the ...
pharmaphorum8d
Bayer reveals phase 3 data for improved MRI contrast agent
The company has reported the first phase 3 results in hand for gadoquatrane, which reduces the dose of gadolinium delivered ...
eLife8d
Alternatives to Friction Coefficient: Fine Touch Perception Relies on Frictional Instabilities
This useful study integrates experimental methods from materials science with psychophysical methods to investigate how frictional stabilities influence tactile surface discrimination. The authors ...
Le Lézard8d
Sanochemia/SPL: Investigational Iron-Based MRI Contrast Agent Meets Primary Endpoints in Pivotal Phase III Study
Sanochemia Pharmazeutika today announced positive headline results of the pivotal phase III study PROSTAPROGRESS on Ferumoxtran (EudraCT 2018-004310-18), performed by SPL Medical B.V. (Nijmegen, The ...
The Grand Junction Daily Sentinel9d
Doctors detect lung abnormalities in kids and teens with long COVID
The researchers employed phase-resolved functional lung (PREFUL ... abnormalities in pediatric post-COVID-19 conditions using ...
The Australian15d
Imagion to start production of MagSense imaging agent for phase II breast cancer trial
Manufacturing will start on new batch of Imagion’s MagSense HER2 breast cancer imaging agent for its intended phase II trial ... HER2 imaging agent for human clinical investigational use ...
KVIA16d
UN human rights chief accuses Rwanda-backed rebels in eastern DR Congo of killing and recruiting children
(AP) — The UN human rights chief accused Rwanda-backed rebels who seized a second major city in eastern Democratic Republic of Congo (DRC) of killing children and attacking hospitals and ...
Philippine Daily Inquirer17d
Launch of Pasig River rehab project’s third phase moved
MANILA, Philippines – The launch of the Pasig Bigyang Buhay Muli Phase 3, originally set Monday, was postponed to a later date due to inclement weather. According to Deputy Social Secretary Dina ...
eLife17d
Human Brain-Wide Activation of Sleep Rhythms
Little is known about the associated brain activation during these sleep rhythms, and even less about their functional implications. In this study, we investigated the brain-wide activation underlying ...
Dot Esports23d
When do Human Torch and The Thing come out in Marvel Rivals?
While players enjoy the new heroes, they understandably wonder when The Thing and Human Torch will join them. Marvel’s First Family is at the center of attention in season one of Marvel Rivals.